Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART)

Viral Immunology

Volumn 17, Issue 2, 2004, Pages 279-286

  Torti, Carlo ^a   Cologni, Giuliana ^a   Uccelli, Maria Cristina ^a   Quiros Roldan, Eugenia ^a   Imberti, Luisa ^b   Airo, Paolo ^a   Pirovano, Silvia ^b   Patroni, Andrea ^a   Tirelli, Valeria ^a   Carosi, Giampiero ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Terzo Serv Analisi and Inst Chem   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD45 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 7; PROTEIN BCL 2;

ADULT; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; CELL POPULATION; CELL SURVIVAL; CLINICAL ARTICLE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIROLOGY; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 3042730374     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/0882824041310630     Document Type: Article

References (26)

1. + cell depletion. J. Infect. Dis. 188:1794-1803.
2. Piketty, C., L. Weiss, F. Thomas, et al. 2001. Long-term clinical outcome of HIV-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen. J. Infect. Dis. 183:1328-1335.
3. Le Moing, V., R. Thièbaut, G. Chène, et al. 2002. Predictors of long-term increase in CD4 cell counts in HIV-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J. Infect. Dis. 185:471-480.
4. + cell count relative to plasma viral load in a closely followed cohort of patients initiating antiretroviral therapy. J. Acquir. Immune. Defic. Syndr. 30:159-166.
5. Prati, E., R. Gorla, F. Malacarne, et al. 1997. Study of spontaneous apoptosis in HIV+ patients: correlation with clinical progression and T cell loss. AIDS Res. Hum. Retroviruses 13:1501-1508.
6. Petit, F., D. Arnoult, L. Viollet, et al. 2003. Intrinsic and extrinsic pathways signalling during HIV-1 mediated cell death. Biochemistry 85:795-811.
7. Karawajew, L., V. Ruppert, C. Wuchter, et al. 2000. Inhibition of in vitro spontaneous apoptosis by IL 7 correlates with Bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukaemia. Blood 96:297-306.
8. Arnoult, D., F. Petit, J.D. Lelièvie, et al. 2003. Caspase-dependent and -independent T-cell death pathways in pathogenic simian immunodeficiency virus infection: relationship to disease progression. Cell. Death. Differ. 10:1240-1252.
9. Amicosante, M., F. Poccia, C. Gioia, et al. 2003. Levels of interleukin-15 in plasma may predict a favourable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection. J. Infect. Dis. 188:661-665.
10. Correa, R., S. Resino, and M.A. Munoz-Fernandez. 2003. Increased interleukin-7 levels are associated with recovery of CD4+ T cells in HIV-infected children. J. Clin. Immunol. 23:401-406.
11. Diaz, M., D.C. Douek, H. Valdez, et al. 2003. T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment. AIDS 17:1145-1149.
12. Delgado, J., M. Leal, E. Ruiz-Mateos, et al. 2002. Evidence of thymic function in heavily antiretroviral-treated human immunodeficiency virus type 1-infected adults with long-term virologic treatment failure. J. Infect. Dis. 186:410-414.
13. Geenen, V., J.F. Poulin, M.L. Dion, et al. 2003. Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. J. Endocrinol. 176:305-311.
14. Senn, S., L. Stevens, and N. Chaturvedi. 2000. Repeated measures in clinical trials: simple strategies for analysis using summary measures. Stat. Med. 19:861-877.
15. Deeks, S.G. 2003. Treatment of antiretroviral-drug-resistant HIV-1 infection. Lancet 362:2002-2011.
16. Torti, C., E. Quiros-Roldan, L. Scudeller, et al. 2003. Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study. HIV Med. 4:1-8.
17. Airò, P., C. Torti, M.C. Uccelli, et al. 2000. Naive CD4+ T-lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection. AIDS Res. Hum. Retroviruses 16:1805-1807.
18. Uccelli, M.C., C. Torti, E. Quiros-Roldan, et al. 2003. Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy. AIDS 17:141-143.
19. Chang, K.H., J.M. Kim, H.Y. Kim, et al. 2000. Spontaneous programmed cell death of peripheral blood mononuclear cells from HIV-infected persons is decreased with interleukin 15. Yonsei Med. J. 41:112-118.
20. Naora, H., and M.L. Gougeon. 1999. Interleukin 15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 lymphocytes of HIV-infected individuals. Correlation with its ability to increase Bcl-2 expression. Cell. Death. Differ. 6:1002-1011.
21. + T lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL) 2, IL 15 and Bcl-2. J. Infect. Dis. 187:1735-1747.
22. Guillemard, E., M.T. Nugeyre, L. Chene, et al. 2001. Interleukin-7 and infection itself by human immunodeficiency virus 1 favour virus persistence in mature CD4(+)CD8(-)CD3(+) thymocytes through sustained induction of Bcl-2. Blood 98:2166-2174.
23. Alladin, H., T. Katzenstein, A.M. Dreves, et al. 2003. T-cell receptor excisional circles, telomere lenght, proliferation and apoptosis in peripheral blood mononuclear cells of human immunodeficiency virus-infected individuals after 18 months of treatment induced viral suppression. Scand. J. Immunol. 57:485-492.
24. Richardson, M.W., A.E. Sverstiuk, E.J. Gracely, et al. 2003. T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection. AIDS 17:915-929.
25. Ruiz-Mateos, E., R. de la Rosa, N. Soriano, et al. 2003. Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART. Antivir. Ther. 8:289-294.
26. + T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J. Immunol. 171:61-68.